UY31192A1 - Un nuevo procedimiento para preparar ácido 2-(3-{6-[2,4-diclorofenil)-etilamino]-2-metoxipirimidin-4-il}-fenil)-2-metil-propiónico - Google Patents

Un nuevo procedimiento para preparar ácido 2-(3-{6-[2,4-diclorofenil)-etilamino]-2-metoxipirimidin-4-il}-fenil)-2-metil-propiónico

Info

Publication number
UY31192A1
UY31192A1 UY31192A UY31192A UY31192A1 UY 31192 A1 UY31192 A1 UY 31192A1 UY 31192 A UY31192 A UY 31192A UY 31192 A UY31192 A UY 31192A UY 31192 A1 UY31192 A1 UY 31192A1
Authority
UY
Uruguay
Prior art keywords
phenyl
propionic
methyl
metoxypyrimidin
etilamino
Prior art date
Application number
UY31192A
Other languages
English (en)
Spanish (es)
Inventor
Secord Elizabeth
Matthew R Powers
Huang Bao-Guo
Reda G Hanna
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of UY31192A1 publication Critical patent/UY31192A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/34—One oxygen atom
    • C07D239/36—One oxygen atom as doubly bound oxygen atom or as unsubstituted hydroxy radical

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Otolaryngology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Catalysts (AREA)
UY31192A 2007-06-29 2008-06-27 Un nuevo procedimiento para preparar ácido 2-(3-{6-[2,4-diclorofenil)-etilamino]-2-metoxipirimidin-4-il}-fenil)-2-metil-propiónico UY31192A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US94725607P 2007-06-29 2007-06-29

Publications (1)

Publication Number Publication Date
UY31192A1 true UY31192A1 (es) 2009-01-30

Family

ID=40226759

Family Applications (1)

Application Number Title Priority Date Filing Date
UY31192A UY31192A1 (es) 2007-06-29 2008-06-27 Un nuevo procedimiento para preparar ácido 2-(3-{6-[2,4-diclorofenil)-etilamino]-2-metoxipirimidin-4-il}-fenil)-2-metil-propiónico

Country Status (11)

Country Link
US (1) US20100184979A1 (https=)
EP (1) EP2170837B1 (https=)
JP (1) JP2010532366A (https=)
AR (1) AR067348A1 (https=)
AT (1) ATE531699T1 (https=)
CL (1) CL2008001913A1 (https=)
PA (1) PA8786301A1 (https=)
PE (1) PE20090428A1 (https=)
TW (1) TW200922927A (https=)
UY (1) UY31192A1 (https=)
WO (1) WO2009006086A2 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2576871T3 (es) * 2010-03-23 2016-07-11 Scinopharm Taiwan Ltd. Proceso e intermedios para preparar lapatinib
CN104592137B (zh) * 2014-11-04 2016-09-14 江苏大学 2,2’,2”-[1,3,5-三嗪-2,4,6-三巯基]三丙酸及其合成方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HN2005000795A (es) 2004-10-15 2010-08-19 Aventis Pharma Inc Pirimidinas como antagonistas del receptor de prostaglandina d2
GT200600457A (es) * 2005-10-13 2007-04-27 Aventis Pharma Inc Sal de fosfato dihidrogeno como antagonistas del receptor de prostaglandina d2
TW201034675A (en) * 2008-12-18 2010-10-01 Sanofi Aventis Method for treating macular degeneration

Also Published As

Publication number Publication date
TW200922927A (en) 2009-06-01
WO2009006086A2 (en) 2009-01-08
WO2009006086A3 (en) 2009-03-12
JP2010532366A (ja) 2010-10-07
ATE531699T1 (de) 2011-11-15
EP2170837A2 (en) 2010-04-07
AR067348A1 (es) 2009-10-07
PA8786301A1 (es) 2009-01-23
CL2008001913A1 (es) 2009-01-16
PE20090428A1 (es) 2009-05-04
EP2170837B1 (en) 2011-11-02
US20100184979A1 (en) 2010-07-22

Similar Documents

Publication Publication Date Title
CL2016000346A1 (es) Proceso para preparar compuestos intermediarios en la preparación de pirazolil pirrol pirimidinas.
CR11780A (es) Nuevo proceso para la sintesis de ivabradina y sales de adicion resultantes con un acido farmaceuticamente aceptable (solicitud divisonal)
CR9369A (es) Compuestos de peridil acido acetico
DK3686193T3 (da) 2-(2,4,5-substitueret anilino)pyrimidinforbindelser
PT2017566E (pt) Acoplamento rápido especialmente para a coronha de uma arma portátil
CR10704A (es) Forma cristalina 2-cloro-5-[3,6-dihidro-3-metil-2,6-dioxo-4-(trifluorometil)-1-(2h)-pirimidinil]-4-fluoro-n-[[metil (1-metiletil) amino]sulfonil]benzamida
MX2010002902A (es) Pirimidinas anti-infecciosas y usos de las mismas.
CL2009000576A1 (es) Un compuesto {1-etilsulfonil-3-[4-(7h-pirrolo[2,3-d]pirimidin-4-il)-1h-pirazol-1-il]azetidin-3-il}acetonitrilo o su sal; inhibidor de jak; composicion farmaceutica; y su uso para tratar artritis reumatoide.
BRPI0815139A2 (pt) Processo para a produção de sistemas de revestimento duros à base de dispersões aquosas de poliuretano
EP2238239A4 (en) BIOLOGICAL SYSTEMS FOR THE MANUFACTURE OF COMMERCIAL VALUABLE COMPOUNDS
CU20090141A7 (es) Compuestos 2-amino pirimidina
NI200900151A (es) Nuevo procedimiento de síntesis de la agomelatina.
MY149535A (en) Process for continuously preparing methyl mercaptan from carbon-and hydrogen-containing compounds
AR064658A1 (es) Proceso para preparar duloxetina y sus compuestos relacionados, asi como tambien intermediarios utiles en la misma
BRPI0815754A2 (pt) métodos para preparar compostos à base de 4-fenil-6-(2,2,2-trifluoro-1-feniletóxi)pirimidina
UY31192A1 (es) Un nuevo procedimiento para preparar ácido 2-(3-{6-[2,4-diclorofenil)-etilamino]-2-metoxipirimidin-4-il}-fenil)-2-metil-propiónico
CL2011002278A1 (es) Proceso para la preparacion de (e)-n-(4-(3-ter-butil-5-(2,4-dioxo-3,4-dihidropirimidin-1(2h)-il)-2-metoxiestiril)fenil)metansulfonamida o su sal por reduccion del correspondiente etinilo; y los compuestos intermediarios considerados.
CU20090131A7 (es) Nuevo proceso de síntesis industrial de agomelatina
WO2010038008A3 (en) Co-crystals
BRPI0919188A2 (pt) processo para a purificação de metanol por destilação.
TH100708B (th) กระบวนการใหม่สำหรับการเตรียม 2-(3-{6-[2-(2,4-ไดคลอโรเฟนิล)-เอธิลอะมิโน]-2-เมธอกซีไพริมิดิน-4-อิล}-เฟนิล)-2-เมธิลโพรไพโอนิค แอซิด
UY31191A1 (es) Proceso para la preparación de ácido (2r)-2-[4-(7-bromo-2-quinoliloxi)fenoxi]propanoico
TH100708A (th) กระบวนการใหม่สำหรับการเตรียม 2-(3-{6-[2-(2,4-ไดคลอโรเฟนิล)-เอธิลอะมิโน]-2-เมธอกซีไพริมิดิน-4-อิล}-เฟนิล)-2-เมธิลโพรไพโอนิค แอซิด
CU23386A3 (es) Nuevo metodo para la sintesis industrial de ranelato de estroncio y los hidratos del mismo
ES1065083Y (es) Estuche para la identificacion de piezas de caza.

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20130205